Retraction notices

The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo

Type

Retraction

Notice date

5/24/2019 0:00

Journal

Blood

Publisher

American Society of Hematology

Notice DOI

10.1182/blood-2019-05-901223

Original paper DOI

10.1182/blood-2009-12-257261

Reasons

• Duplication of/in Image
• Falsification/Fabrication of Data
• Investigation by Company/Institution
• Investigation by ORI
• Misconduct - Official Investigation(s) and/or Finding(s)
• Misconduct by Author

Matching venue names

Name match only, not an authoritative journal identifier.

• Blood